Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan
Status:
Enrolling by invitation
Trial end date:
2030-03-01
Target enrollment:
Participant gender:
Summary
This study is a randomized open-label single-blind non-inferiority comparative effectiveness
study of ECT vs. KET for the treatment of Acute Suicidal Depression (ASD).
Phase:
Phase 4
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborators:
Baylor College of Medicine Icahn School of Medicine at Mount Sinai Johns Hopkins University The Cleveland Clinic The University of Texas Health Science Center, Houston University of Arizona University of Pittsburgh University of Toronto Washington University School of Medicine